☆ 4.6 Article

Circulating S-Glutathionylated cMyBP-C as a Biomarker for Cardiac Diastolic Dysfunction

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

Cellular and molecular pathobiology of heart failure with preserved ejection fraction

Sumita Mishra et al.

Summary: Heart failure with preserved ejection fraction (HFpEF) is a complex multiorgan syndrome involving the heart, lungs, kidneys, skeletal muscle, adipose tissue, vascular system, and immune and inflammatory signaling. It is challenging to model in experimental animals due to its multiorgan involvement, but new animal models and efforts to examine human pathophysiology are revealing potential therapeutic targets. Research is focusing on cellular and molecular pathobiology of HFpEF, with efforts to understand mechanisms relevant to the heart as well as other organ systems, in order to develop more patient-specific therapies and improve clinical outcomes.

NATURE REVIEWS CARDIOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Magnesium supplementation improves diabetic mitochondrial and cardiac diastolic function

Man Liu et al.

JCI INSIGHT (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study An Echocardiographic Study Over 3 Decades

Ramachandran S. Vasan et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction

Gilman D. Plitt et al.

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction

Euy-Myoung Jeong et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiac MyBP-C Regulates the Rate and Force of Contraction in Mammalian Myocardium

Richard L. Moss et al.

CIRCULATION RESEARCH (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties

Euy-Myoung Jeong et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium Sensitivity

Joshua D. Lovelock et al.

CIRCULATION RESEARCH (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study

Viviane M. Conraads et al.

EUROPEAN JOURNAL OF HEART FAILURE (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice

Bodvael Fraysse et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction

Suresh Govindan et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.